Management of iron deficiency in patients admitted to hospital: time for a rethink of treatment principles

被引:15
作者
Ahmad, I.
Gibson, P. R.
机构
[1] Box Hill Hosp, Dept Gastroenterol, Box Hill, Vic, Australia
[2] Monash Univ, Dept Med, Clayton, Vic 3168, Australia
[3] Maroondah Hosp, Dept Gastroenterol, Melbourne, Vic, Australia
关键词
iron repletion; iron polymaltose; iron sucrose; total dose iron infusion; blood transfusion;
D O I
10.1111/j.1445-5994.2006.01084.x
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background: Iron deficiency is very common in patients admitted to hospital. Its management is changing with new insights into iron absorption and therapeutic options. Aims: The aims of this study were to develop guidelines for the correction of iron deficiency in patients admitted to hospital and to compare these with current practice. Methods: Based on current published evidence, guidelines were developed. All patients in whom iron deficiency was detected during hospital admission over a 2.5 year period were retrospectively studied. Their management was compared with that of the guidelines developed. Results: Three clinical scenarios were identified-(A) urgent attention to haemoglobin required: blood transfusion followed by i.v. iron recommended, (B) Semiurgent iron repletion: i.v. iron recommended and (C) non-urgent iron repletion: oral or i.v. repletion recommended. A total of 119 patients was identified, age 18-99 (median 77) years, 29% men, and haemoglobin 33-130 (87) g/L. Of 66 given blood transfusion, 17 had subsequent i.v. iron, 25 oral iron and 24 no other form of iron repletion. Of the other 53, nine had i.v. iron, 32 oral iron and 12 had no treatment. Fifty-five per cent of patients were managed according to the proposed guidelines and this occurred less frequently (9%) in those presenting with cardiovascular problems than in those with anaemia, gastrointestinal bleeding or other medical problems (all > 60%; P < 0.0001, Fisher's exact test). Conclusion: Current management is haphazard, with underutilization of i.v. iron and failure to initiate any regimen for iron repletion being common. It may be time for a change in approach to repletion of iron in ill patients.
引用
收藏
页码:347 / 354
页数:8
相关论文
共 40 条
[1]
Issues related to iron replacement in chronic kidney disease [J].
Agarwal, R ;
Warnock, D .
SEMINARS IN NEPHROLOGY, 2002, 22 (06) :479-487
[2]
Ahsan N, 1998, J AM SOC NEPHROL, V9, P664
[3]
Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy [J].
AlMomen, AK ;
AlMeshari, A ;
AlNuaim, L ;
Saddique, A ;
Abotalib, Z ;
Khashogji, T ;
Abbas, M .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1996, 69 (02) :121-124
[4]
Iron pre-load for major joint replacement [J].
Andrews, CM ;
Lane, DW ;
Bradley, JG .
TRANSFUSION MEDICINE, 1997, 7 (04) :281-286
[5]
Iron therapy in iron deficiency anemia in pregnancy: Intravenous route versus oral route [J].
Bayoumeu, F ;
Subiran-Buisset, C ;
Baka, NE ;
Legagneur, H ;
Monnier-Barbarino, P ;
Laxenaire, MC .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2002, 186 (03) :518-522
[6]
Treatment of anaemia in inflammatory bowel disease with iron sucrose [J].
Bodemar, G ;
Kechagias, S ;
Almer, S ;
Danielson, BG .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2004, 39 (05) :454-458
[7]
Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls [J].
Bruner, AB ;
Joffe, A ;
Duggan, AK ;
Casella, JF ;
Brandt, J .
LANCET, 1996, 348 (9033) :992-996
[8]
Intravenous iron sucrose: Establishing a safe dose [J].
Chandler, G ;
Harchowal, J ;
Macdougall, IC .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (05) :988-991
[9]
Oral iron therapy in inflammatory bowel disease: Usage, tolerance, and efficacy [J].
de Silva, AD ;
Mylonaki, M ;
Rampton, DS .
INFLAMMATORY BOWEL DISEASES, 2003, 9 (05) :316-320
[10]
Hepcidin:: a molecular link between inflammation and anaemia [J].
Deicher, R ;
Hörl, WH .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (03) :521-524